Loading clinical trials...
Loading clinical trials...
Real World Outcomes Using Novel Agents for Acute Myeloid Leukaemia in the United Kingdom
Conditions
Interventions
Venetoclax
Gilteritinib
Locations
1
United Kingdom
Guy's and St Thomas' NHS Foundation Trust
London, United Kingdom
Start Date
May 1, 2022
Primary Completion Date
October 1, 2023
Completion Date
October 1, 2023
Last Updated
March 2, 2023
NCT06285890
NCT06220162
NCT04065399
NCT04628026
NCT06994676
NCT06484062
Lead Sponsor
Guy's and St Thomas' NHS Foundation Trust
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions